Elicio Therapeutics Activates Phase 1 Study of ELI-002 7P
Boston, Aug. 10, 2026 Elicio Therapeutics, Inc. announced the activation of an investigator-initiated Phase 1 clinical study evaluating its...
in vitro diagnostics
Advertisement
Telomir Pharmaceuticals Publishes Telomir-Zn Cancer Data
Miami, August 10, 2026 Telomir Pharmaceuticals, Inc. announced the peer-reviewed publication of preclinical data showing that Telomir-Zn suppressed tumor...
Ibex Medical Analytics Strengthens Breast Cancer AI with CE-IVDR Approval
Boston and Tel Aviv, Israel, July 23, 2026 Ibex Medical Analytics announced it has received CE-IVDR certification for Ibex...
Bluejay Completes Patient Enrollment in SYMON-II Trial
Acton, Massachusetts, USA | July 21, 2026 Bluejay Diagnostics has announced the successful completion of patient enrollment in its...
Moderna and Oxford Launch Phase 1/2 Trial of mRNA Cancer Vaccine for Lynch Syndrome
OXFORD, UK AND CAMBRIDGE, Massachusetts – June 8, 2026 Moderna and the University of Oxford have received authorization from...
Advertisements
Johnson & Johnson Acquires Firefly Bio to Boost Oncology
NEW BRUNSWICK, New Jersey, USA – June 8, 2026 Johnson & Johnson has announced a definitive agreement to acquire...
Waters Secures FDA Clearance for BD BACTEC FXI System
MILFORD, Massachusetts, USA – June 3, 2026 Waters Corporation has announced U.S. Food and Drug Administration (FDA) 510(k) clearance...
Global Immunoassays Market to Reach USD 42.77 Billion by 2034 Driven by Advanced Diagnostics and Precision Medicine
OTTAWA, November 5, 2025 — A new market report from Nova One Advisor, a subsidiary of Precedence Research, projects...
Advertisement
